Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Insulin Resistance | 17 | 2024 | 461 | 4.900 |
Why?
|
Adipose Tissue | 17 | 2024 | 347 | 4.260 |
Why?
|
Obesity | 16 | 2024 | 1179 | 2.900 |
Why?
|
Gene Expression Regulation | 14 | 2024 | 494 | 2.770 |
Why?
|
Polymorphism, Single Nucleotide | 29 | 2022 | 1067 | 2.480 |
Why?
|
Diabetes Mellitus, Type 2 | 25 | 2022 | 1428 | 2.360 |
Why?
|
DNA Methylation | 4 | 2024 | 140 | 2.110 |
Why?
|
African Americans | 18 | 2020 | 1428 | 1.930 |
Why?
|
Genetic Predisposition to Disease | 17 | 2022 | 835 | 1.840 |
Why?
|
Subcutaneous Fat | 6 | 2017 | 47 | 1.760 |
Why?
|
Chromosomes, Human, Pair 1 | 10 | 2013 | 38 | 1.760 |
Why?
|
Glucose | 9 | 2020 | 174 | 1.650 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 104 | 1.600 |
Why?
|
European Continental Ancestry Group | 20 | 2019 | 1169 | 1.590 |
Why?
|
Muscles | 3 | 2018 | 62 | 1.150 |
Why?
|
Gene Expression Profiling | 6 | 2023 | 323 | 1.130 |
Why?
|
Muscle, Skeletal | 8 | 2016 | 518 | 1.130 |
Why?
|
Polymorphism, Genetic | 10 | 2010 | 184 | 1.130 |
Why?
|
Quantitative Trait Loci | 6 | 2019 | 140 | 1.060 |
Why?
|
Genome-Wide Association Study | 10 | 2022 | 549 | 0.980 |
Why?
|
Adult | 32 | 2024 | 9367 | 0.980 |
Why?
|
Humans | 65 | 2024 | 32025 | 0.900 |
Why?
|
Middle Aged | 32 | 2024 | 11868 | 0.880 |
Why?
|
Adipocytes | 3 | 2019 | 80 | 0.870 |
Why?
|
Insulin | 8 | 2018 | 366 | 0.800 |
Why?
|
Male | 38 | 2024 | 19196 | 0.740 |
Why?
|
Thiazolidinediones | 2 | 2012 | 47 | 0.720 |
Why?
|
Female | 36 | 2024 | 19954 | 0.720 |
Why?
|
Enoyl-CoA Hydratase | 1 | 2019 | 4 | 0.670 |
Why?
|
Hypoglycemic Agents | 2 | 2012 | 181 | 0.660 |
Why?
|
Transferrin | 1 | 2018 | 33 | 0.650 |
Why?
|
Adiposity | 2 | 2018 | 199 | 0.640 |
Why?
|
African Continental Ancestry Group | 6 | 2015 | 363 | 0.610 |
Why?
|
Endoplasmic Reticulum | 4 | 2012 | 24 | 0.590 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2015 | 80 | 0.590 |
Why?
|
Young Adult | 11 | 2018 | 2615 | 0.580 |
Why?
|
Triglycerides | 2 | 2017 | 230 | 0.580 |
Why?
|
Cholesterol, HDL | 1 | 2017 | 177 | 0.570 |
Why?
|
Phenotype | 9 | 2022 | 639 | 0.550 |
Why?
|
Allelic Imbalance | 2 | 2013 | 6 | 0.540 |
Why?
|
Gene Expression | 7 | 2022 | 335 | 0.530 |
Why?
|
Computational Biology | 4 | 2020 | 91 | 0.530 |
Why?
|
Prediabetic State | 3 | 2017 | 65 | 0.500 |
Why?
|
Glucose Tolerance Test | 6 | 2017 | 125 | 0.490 |
Why?
|
Genotype | 11 | 2019 | 734 | 0.490 |
Why?
|
Adolescent | 13 | 2018 | 3526 | 0.480 |
Why?
|
Body Mass Index | 9 | 2022 | 923 | 0.470 |
Why?
|
Biosynthetic Pathways | 1 | 2013 | 3 | 0.450 |
Why?
|
Genetics, Population | 2 | 2005 | 32 | 0.450 |
Why?
|
Phospholipids | 1 | 2013 | 28 | 0.440 |
Why?
|
Blood Glucose | 3 | 2014 | 492 | 0.430 |
Why?
|
Genetic Testing | 1 | 2013 | 96 | 0.430 |
Why?
|
MicroRNAs | 1 | 2015 | 180 | 0.420 |
Why?
|
Chromosome Mapping | 9 | 2016 | 193 | 0.410 |
Why?
|
Genome, Human | 3 | 2009 | 132 | 0.400 |
Why?
|
Case-Control Studies | 10 | 2018 | 897 | 0.400 |
Why?
|
Mutation | 6 | 2008 | 488 | 0.390 |
Why?
|
Thioredoxin Reductase 1 | 1 | 2011 | 2 | 0.390 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 110 | 0.370 |
Why?
|
Oleic Acid | 1 | 2010 | 7 | 0.360 |
Why?
|
Palmitates | 1 | 2010 | 4 | 0.360 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 88 | 0.360 |
Why?
|
Osteocalcin | 1 | 2010 | 9 | 0.350 |
Why?
|
Oxidative Stress | 1 | 2011 | 231 | 0.340 |
Why?
|
RNA, Messenger | 7 | 2013 | 508 | 0.330 |
Why?
|
Cell Line | 4 | 2018 | 435 | 0.330 |
Why?
|
Stress, Physiological | 2 | 2008 | 55 | 0.330 |
Why?
|
Membrane Proteins | 5 | 2017 | 257 | 0.320 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2008 | 2 | 0.310 |
Why?
|
Glaucoma, Open-Angle | 2 | 2018 | 22 | 0.310 |
Why?
|
Down-Regulation | 3 | 2014 | 142 | 0.300 |
Why?
|
Globins | 3 | 2002 | 8 | 0.290 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2006 | 17 | 0.280 |
Why?
|
Cardiovascular Diseases | 1 | 2014 | 1125 | 0.280 |
Why?
|
Metabolomics | 2 | 2024 | 54 | 0.270 |
Why?
|
India | 11 | 2005 | 61 | 0.270 |
Why?
|
Databases, Genetic | 1 | 2005 | 37 | 0.260 |
Why?
|
Calsequestrin | 1 | 2004 | 2 | 0.250 |
Why?
|
Gene Knockdown Techniques | 2 | 2018 | 77 | 0.250 |
Why?
|
DNA Mutational Analysis | 3 | 2002 | 72 | 0.250 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 114 | 0.240 |
Why?
|
Homeostasis | 3 | 2015 | 132 | 0.240 |
Why?
|
Liver | 6 | 2017 | 483 | 0.230 |
Why?
|
Animals | 10 | 2023 | 7466 | 0.230 |
Why?
|
PPAR gamma | 3 | 2014 | 46 | 0.230 |
Why?
|
Quantitative Trait, Heritable | 2 | 2013 | 47 | 0.220 |
Why?
|
Gene Regulatory Networks | 1 | 2023 | 41 | 0.210 |
Why?
|
Nerve Tissue Proteins | 3 | 2017 | 120 | 0.210 |
Why?
|
Linkage Disequilibrium | 9 | 2009 | 186 | 0.210 |
Why?
|
Sequence Deletion | 2 | 2009 | 40 | 0.210 |
Why?
|
Aged | 13 | 2018 | 10340 | 0.210 |
Why?
|
Acetyl-CoA Carboxylase | 2 | 2013 | 23 | 0.210 |
Why?
|
beta-Thalassemia | 5 | 2002 | 11 | 0.200 |
Why?
|
Gene Frequency | 7 | 2018 | 220 | 0.190 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2001 | 10 | 0.190 |
Why?
|
Fetal Hemoglobin | 1 | 2001 | 4 | 0.190 |
Why?
|
Genomics | 2 | 2011 | 84 | 0.180 |
Why?
|
Waist-Hip Ratio | 4 | 2013 | 34 | 0.180 |
Why?
|
Exons | 3 | 2010 | 52 | 0.170 |
Why?
|
Biopsy | 2 | 2023 | 260 | 0.170 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2017 | 68 | 0.170 |
Why?
|
TCF Transcription Factors | 2 | 2010 | 8 | 0.160 |
Why?
|
Phosphopyruvate Hydratase | 1 | 2018 | 11 | 0.160 |
Why?
|
Ferritins | 1 | 2018 | 46 | 0.160 |
Why?
|
Blotting, Western | 1 | 2019 | 292 | 0.160 |
Why?
|
Macrophages | 2 | 2022 | 192 | 0.160 |
Why?
|
Cross-Sectional Studies | 3 | 2018 | 1530 | 0.150 |
Why?
|
Activating Transcription Factor 6 | 2 | 2008 | 3 | 0.150 |
Why?
|
Iron | 1 | 2018 | 115 | 0.150 |
Why?
|
Inflammation | 2 | 2012 | 540 | 0.150 |
Why?
|
Methylamines | 1 | 2017 | 2 | 0.150 |
Why?
|
Oxygenases | 1 | 2017 | 3 | 0.150 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2017 | 9 | 0.150 |
Why?
|
Dietary Fiber | 1 | 2017 | 19 | 0.150 |
Why?
|
Cohort Studies | 3 | 2018 | 1831 | 0.140 |
Why?
|
Fatty Acids | 2 | 2022 | 98 | 0.140 |
Why?
|
Europe | 3 | 2004 | 83 | 0.130 |
Why?
|
Bipolar Disorder | 2 | 2005 | 16 | 0.130 |
Why?
|
Schizophrenia | 2 | 2005 | 31 | 0.130 |
Why?
|
Haplotypes | 5 | 2006 | 220 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2014 | 15 | 0.120 |
Why?
|
Zebrafish | 1 | 2014 | 23 | 0.120 |
Why?
|
Promoter Regions, Genetic | 2 | 2014 | 208 | 0.120 |
Why?
|
G-Quadruplexes | 2 | 2012 | 8 | 0.120 |
Why?
|
Muscle Proteins | 1 | 2014 | 59 | 0.120 |
Why?
|
Sequence Analysis, DNA | 4 | 2008 | 137 | 0.120 |
Why?
|
Regulatory Sequences, Nucleic Acid | 2 | 2006 | 24 | 0.120 |
Why?
|
Carrier Proteins | 2 | 2013 | 137 | 0.120 |
Why?
|
Genetic Association Studies | 2 | 2013 | 146 | 0.120 |
Why?
|
Phosphatidylethanolamine N-Methyltransferase | 1 | 2013 | 1 | 0.110 |
Why?
|
Thiolester Hydrolases | 1 | 2013 | 1 | 0.110 |
Why?
|
Hep G2 Cells | 2 | 2010 | 26 | 0.110 |
Why?
|
Receptors, Immunologic | 1 | 2013 | 21 | 0.110 |
Why?
|
3' Untranslated Regions | 1 | 2013 | 24 | 0.110 |
Why?
|
Luciferases | 1 | 2013 | 32 | 0.110 |
Why?
|
Cells, Cultured | 3 | 2014 | 833 | 0.110 |
Why?
|
Ligands | 1 | 2012 | 80 | 0.100 |
Why?
|
PPAR alpha | 1 | 2012 | 29 | 0.100 |
Why?
|
DNA | 3 | 2009 | 228 | 0.100 |
Why?
|
Metabolism | 1 | 2011 | 7 | 0.100 |
Why?
|
Genetic Variation | 6 | 2010 | 245 | 0.100 |
Why?
|
Adiponectin | 1 | 2012 | 106 | 0.100 |
Why?
|
Nuclear Proteins | 1 | 2011 | 74 | 0.100 |
Why?
|
Arkansas | 2 | 2008 | 2 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 261 | 0.100 |
Why?
|
Diabetic Nephropathies | 1 | 2013 | 224 | 0.100 |
Why?
|
Transcription, Genetic | 1 | 2012 | 137 | 0.100 |
Why?
|
DNA-Binding Proteins | 2 | 2009 | 147 | 0.090 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 197 | 0.090 |
Why?
|
Neoplasm Proteins | 1 | 2011 | 148 | 0.090 |
Why?
|
Up-Regulation | 1 | 2011 | 189 | 0.090 |
Why?
|
Transcription Factors | 2 | 2009 | 180 | 0.090 |
Why?
|
Dual-Specificity Phosphatases | 2 | 2008 | 5 | 0.090 |
Why?
|
Drug Interactions | 1 | 2010 | 79 | 0.090 |
Why?
|
Alternative Splicing | 1 | 2010 | 30 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 73 | 0.090 |
Why?
|
Adaptation, Physiological | 1 | 2010 | 57 | 0.090 |
Why?
|
Risk Factors | 4 | 2022 | 3869 | 0.090 |
Why?
|
Lymphocytes | 1 | 2010 | 57 | 0.090 |
Why?
|
Mice, Knockout | 3 | 2017 | 444 | 0.090 |
Why?
|
Recombination, Genetic | 1 | 2009 | 22 | 0.080 |
Why?
|
Body Composition | 1 | 2011 | 396 | 0.080 |
Why?
|
Transcription Factor CHOP | 1 | 2008 | 3 | 0.080 |
Why?
|
Endoribonucleases | 1 | 2008 | 4 | 0.080 |
Why?
|
eIF-2 Kinase | 1 | 2008 | 6 | 0.080 |
Why?
|
Molecular Chaperones | 1 | 2008 | 13 | 0.080 |
Why?
|
Family Health | 3 | 2008 | 76 | 0.080 |
Why?
|
Pedigree | 3 | 2008 | 140 | 0.080 |
Why?
|
Intraocular Pressure | 2 | 2018 | 40 | 0.080 |
Why?
|
Heat-Shock Proteins | 1 | 2008 | 34 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2014 | 767 | 0.080 |
Why?
|
Protein-Serine-Threonine Kinases | 1 | 2008 | 50 | 0.080 |
Why?
|
Lipids | 2 | 2022 | 229 | 0.080 |
Why?
|
Hemoglobin E | 2 | 1997 | 2 | 0.070 |
Why?
|
Pyruvate Kinase | 2 | 2009 | 2 | 0.070 |
Why?
|
Mice | 4 | 2017 | 2475 | 0.070 |
Why?
|
International Cooperation | 1 | 2007 | 28 | 0.070 |
Why?
|
Genome, Bacterial | 1 | 2006 | 6 | 0.070 |
Why?
|
Guanine | 1 | 2006 | 15 | 0.070 |
Why?
|
DNA, Bacterial | 1 | 2006 | 27 | 0.070 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2005 | 3 | 0.070 |
Why?
|
Mannose-Binding Lectin | 1 | 2005 | 1 | 0.070 |
Why?
|
Homocysteine | 1 | 2005 | 14 | 0.070 |
Why?
|
Escherichia coli | 1 | 2006 | 87 | 0.070 |
Why?
|
Gene Dosage | 1 | 2005 | 35 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2005 | 40 | 0.060 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2005 | 94 | 0.060 |
Why?
|
Prognosis | 1 | 2010 | 1505 | 0.060 |
Why?
|
Lipase | 2 | 2017 | 28 | 0.060 |
Why?
|
Introns | 1 | 2004 | 39 | 0.060 |
Why?
|
Time Factors | 1 | 2010 | 2152 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 131 | 0.060 |
Why?
|
Genetic Markers | 1 | 2004 | 124 | 0.060 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2003 | 2 | 0.060 |
Why?
|
Receptors, Retinoic Acid | 1 | 2003 | 9 | 0.060 |
Why?
|
Peptides | 1 | 2004 | 119 | 0.060 |
Why?
|
Primates | 1 | 2023 | 104 | 0.050 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2002 | 1 | 0.050 |
Why?
|
Zinc Compounds | 1 | 2002 | 4 | 0.050 |
Why?
|
Chlorides | 1 | 2002 | 13 | 0.050 |
Why?
|
Reference Values | 3 | 2009 | 247 | 0.050 |
Why?
|
Leukocytes | 1 | 2002 | 59 | 0.050 |
Why?
|
Locus Control Region | 1 | 2002 | 1 | 0.050 |
Why?
|
Alleles | 3 | 2012 | 248 | 0.050 |
Why?
|
Collagen | 1 | 2022 | 225 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2022 | 189 | 0.050 |
Why?
|
Organ Specificity | 2 | 2012 | 80 | 0.050 |
Why?
|
Hemoglobinopathies | 1 | 2001 | 1 | 0.050 |
Why?
|
Hemoglobins, Abnormal | 1 | 2001 | 1 | 0.050 |
Why?
|
Social Conditions | 1 | 2001 | 2 | 0.050 |
Why?
|
Malaria | 1 | 2001 | 11 | 0.050 |
Why?
|
Geography | 1 | 2001 | 34 | 0.050 |
Why?
|
Cytokines | 1 | 2022 | 260 | 0.050 |
Why?
|
Ethnic Groups | 2 | 2009 | 476 | 0.050 |
Why?
|
Politics | 1 | 2001 | 22 | 0.050 |
Why?
|
Emigration and Immigration | 1 | 2001 | 31 | 0.050 |
Why?
|
Commerce | 1 | 2001 | 43 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2001 | 74 | 0.050 |
Why?
|
Lod Score | 2 | 2011 | 72 | 0.040 |
Why?
|
Indians, North American | 2 | 2013 | 109 | 0.040 |
Why?
|
ROC Curve | 1 | 2018 | 167 | 0.040 |
Why?
|
Body Constitution | 1 | 2018 | 25 | 0.040 |
Why?
|
Visual Fields | 1 | 2018 | 27 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2010 | 464 | 0.040 |
Why?
|
Utah | 2 | 2008 | 15 | 0.040 |
Why?
|
Nucleic Acid Conformation | 2 | 2009 | 48 | 0.040 |
Why?
|
Deuterium | 1 | 2017 | 9 | 0.040 |
Why?
|
Visual Acuity | 1 | 2018 | 73 | 0.040 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 6 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2017 | 13 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 82 | 0.040 |
Why?
|
Dietary Fats | 1 | 2017 | 111 | 0.030 |
Why?
|
Research Design | 1 | 2018 | 312 | 0.030 |
Why?
|
Orphan Nuclear Receptors | 1 | 2014 | 8 | 0.030 |
Why?
|
Azacitidine | 1 | 2014 | 28 | 0.030 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 766 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2014 | 108 | 0.030 |
Why?
|
Random Allocation | 1 | 2014 | 220 | 0.030 |
Why?
|
Cell Movement | 1 | 2014 | 170 | 0.030 |
Why?
|
Cell-Matrix Junctions | 1 | 2013 | 1 | 0.030 |
Why?
|
alpha Catenin | 1 | 2013 | 1 | 0.030 |
Why?
|
GRB10 Adaptor Protein | 1 | 2013 | 1 | 0.030 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2013 | 3 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2013 | 10 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 35 | 0.030 |
Why?
|
Demography | 1 | 2013 | 110 | 0.030 |
Why?
|
Tunicamycin | 1 | 2012 | 6 | 0.030 |
Why?
|
Thapsigargin | 1 | 2012 | 8 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2013 | 104 | 0.030 |
Why?
|
Palmitic Acid | 1 | 2012 | 12 | 0.030 |
Why?
|
Insulin-Secreting Cells | 1 | 2012 | 53 | 0.030 |
Why?
|
Pan troglodytes | 1 | 2012 | 7 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2012 | 34 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2011 | 50 | 0.020 |
Why?
|
Phosphorylation | 1 | 2012 | 230 | 0.020 |
Why?
|
RNA | 1 | 2012 | 92 | 0.020 |
Why?
|
Base Sequence | 1 | 2012 | 251 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2012 | 356 | 0.020 |
Why?
|
Family | 1 | 2011 | 117 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2013 | 771 | 0.020 |
Why?
|
Rats | 1 | 2014 | 1596 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2010 | 57 | 0.020 |
Why?
|
Homozygote | 2 | 2002 | 58 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2012 | 725 | 0.020 |
Why?
|
Stem Cells | 1 | 2012 | 313 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2009 | 27 | 0.020 |
Why?
|
Pancreas | 1 | 2010 | 104 | 0.020 |
Why?
|
Waist Circumference | 1 | 2008 | 90 | 0.020 |
Why?
|
Apolipoprotein A-II | 1 | 2008 | 6 | 0.020 |
Why?
|
Retinoid X Receptor gamma | 1 | 2008 | 2 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2008 | 51 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2008 | 45 | 0.020 |
Why?
|
Models, Genetic | 1 | 2008 | 94 | 0.020 |
Why?
|
Societies, Medical | 1 | 2008 | 162 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2008 | 66 | 0.020 |
Why?
|
Asian Continental Ancestry Group | 1 | 2007 | 108 | 0.020 |
Why?
|
Genes, Regulator | 1 | 2006 | 5 | 0.020 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2006 | 8 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2006 | 20 | 0.020 |
Why?
|
Hydrogen Bonding | 1 | 2006 | 22 | 0.020 |
Why?
|
Models, Chemical | 1 | 2006 | 34 | 0.020 |
Why?
|
Child, Preschool | 2 | 2002 | 1269 | 0.020 |
Why?
|
Gene Components | 1 | 2005 | 3 | 0.020 |
Why?
|
Sex Factors | 1 | 2008 | 663 | 0.020 |
Why?
|
Nucleic Acid Denaturation | 1 | 2005 | 5 | 0.020 |
Why?
|
DNA Primers | 1 | 2005 | 90 | 0.020 |
Why?
|
Schizophrenia, Catatonic | 1 | 2005 | 2 | 0.020 |
Why?
|
Logistic Models | 1 | 2008 | 781 | 0.020 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2005 | 20 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2005 | 128 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2005 | 50 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2013 | 4000 | 0.020 |
Why?
|
Cysteine | 1 | 2005 | 138 | 0.020 |
Why?
|
Age Factors | 1 | 2008 | 1194 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2005 | 161 | 0.010 |
Why?
|
Sequence Analysis | 1 | 2003 | 5 | 0.010 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2003 | 2 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2003 | 5 | 0.010 |
Why?
|
Child | 2 | 2002 | 2441 | 0.010 |
Why?
|
Risk Assessment | 1 | 2009 | 1435 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2004 | 104 | 0.010 |
Why?
|
Micronucleus Tests | 1 | 2002 | 4 | 0.010 |
Why?
|
Trinucleotide Repeats | 1 | 2002 | 9 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2002 | 13 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2002 | 14 | 0.010 |
Why?
|
Gene Deletion | 1 | 2002 | 66 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 629 | 0.010 |
Why?
|
United States | 1 | 2008 | 3938 | 0.010 |
Why?
|
Infant | 1 | 2002 | 1061 | 0.010 |
Why?
|
Codon | 1 | 1997 | 9 | 0.010 |
Why?
|
Point Mutation | 1 | 1997 | 27 | 0.010 |
Why?
|
Heterozygote | 1 | 1997 | 57 | 0.010 |
Why?
|